Impact of COVID-19 Lockdown on Short-Term Weight Loss After Bariatric Surgery

Cuadrado-Ayuso, Marta; Jiménez, Pablo Priego; Orduña, Pilar Cobeta; Carretero, José Ignacio Botella; Álvarez, Julio Galindo

doi:10.1007/s11695-023-06476-8

Cited by 1 publication

(2 citation statements)

References 9 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic period had no influence on short-term weight loss results after RYGB in our patient population, and this finding is supported by the observations from the other published studies [ 15 , 16 , 17 ]. The %EBMIL one year after RYGB in our study was 77.9 and 76.2 among the patients operated on during the pandemic and before the pandemic, respectively.…”

Section: Discussionsupporting

confidence: 91%

“…There are contradictory data about short-term weight loss among patients who underwent bariatric surgery before and during the COVID-19 pandemic. Two studies [ 13 , 14 ] have found that patients operated on during the COVID-19 pandemic lost significantly less weight, while four studies did not find any difference [ 15 , 16 , 17 , 18 ]. However, during the COVID-19 pandemic, more maladaptive eating behaviour, leading to loss of control overeating and poor dietary quality, was observed among the patients after bariatric surgery [ 19 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Impact of COVID-19 Pandemic on Weight Loss, Eating Behaviour and Quality of Life after Roux-en-Y Gastric Bypass

Bauraitė,

Gudaitytė,

Maleckas

2023

Medicina

View full text Add to dashboard Cite

Background and Objectives: The global pandemic of coronavirus disease (COVID-19), declared on 11 March 2020, had an extensive impact on bariatric patients. The aim of this study was to evaluate short-term weight loss outcomes, changes in eating behaviour, and health-related quality of life (HRQoL) among patients who had Roux-en-Y gastric bypass (RYGB) before and during the COVID-19 pandemic. Materials and Methods: This cohort study included 72 patients (Group S) who underwent RYGB surgery in the Surgery Department of the Lithuanian University of Health Sciences during the COVID-19 pandemic in the years 2020–2022. Data for the control group (Group C) of 87 patients (operated on in 2010–2012) were collected from a prospective study. The data referred to the period before and a year after the RYGB. The information about patients’ weight changes, hunger, satiety, fullness sensations, appetite, diet, and eating patterns was queried. Eating behaviour and HRQoL evaluation were conducted by the Three-Factor Eating Questionnaire (TFEQ-R18) and the medical outcomes study Short-Form-36 (SF-36), respectively. Results: One year after the surgery, % excess body mass index loss (%EBMIL) was 77.88 (26.33) in Group S, 76.21 (19.98) in Group C, p = 0.663. Patients in Group S tended more to choose snacks between main meals: 79.2% versus 28.7%, p < 0.0001. Cognitive restraint significantly increased in Group S from 45.93 (13.37) up to 54.48 (13.76), p = 0.001; additionally, significantly worse overall health status was found in Group S compared to Group C, 53.27 (24.61) versus 70.11 (31.63), p < 0.0001. Mental HRQoL (50.76 versus 60.52 score, p < 0.0001) and social functioning (44.79 versus 57.90, p < 0.0001) were worse in Group S. Conclusions: In this study, the COVID-19 pandemic had no impact on short-term weight loss after RYGB. However, one year after, RYGB patients tended to snack more, and mental HRQoL and social functioning were worse in the study group.

show abstract

Section: Discussionsupporting

confidence: 91%